| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9284592 | Revue de Pneumologie Clinique | 2005 | 6 Pages |
Abstract
We then discuss human trials, initially experimental then in different bronchopulmonary pathologies related to oxidative stress. Acetaminophen intoxication and pulmonary fibrosis are models for use of NAC. Recent work on COPD appears to show a decrease in exacerbations, improvement in symptoms and quality-of-life, and perhaps a reduction in the alteration of ventilatory function.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
J.-C. Guerin, P. Leophonte, F.-X. Lebas, F. Liard, Ph. Terrioux, P. Boulanger,